Italia markets close in 3 hours 52 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,84+0,01 (+0,11%)
Alla chiusura: 04:00PM EDT
8,78 -0,06 (-0,68%)
Preborsa: 07:13AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente8,83
Aperto8,58
Denaro8,76 x 27000
Lettera0,00 x 800
Min-Max giorno8,53 - 8,85
Intervallo di 52 settimane6,78 - 11,34
Volume8.461.580
Media Volume13.322.048
Capitalizzazione9,226B
Beta (5 anni mensile)1,27
Rapporto PE (ttm)N/D
EPS (ttm)-0,56
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendo27 nov 2017
Stima target 1A10,50
  • GlobeNewswire

    Certara Appoints Rosemary Crane as New Independent Board Member

    PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors, effective July 21, 2022. Her appointment brings the company’s board of directors to eleven members. “We are excited to welcome an accomplished business leader with a proven track record of success join Certara’s Board,” said William F. Feehery, PhD, CEO of Certara. “Rose’s experience in executive leadership

  • GlobeNewswire

    Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.

    Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future salesTeva will receive an exclusive license to bring firibastat to its home market, Israel PARIS, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat difficult-to-treat/resistant hypertension, has today announced the signing of an exclusive